A Moonshot for Cancer
Building on the momentum of World Health Organization’s 90-70-90 strategy for the global elimination of cervical cancer, GIAHC is honored to be a member of the Union for International Cancer Control and participate on the Cervical Cancer Forum of President Biden’s Cancer Moonshot initiative.
Following are GIAHC activities pertaining towards achieving the above outlined WHO goals.
GIAHC is honored to be a part of the Quad Cancer Moonshot team
GIAHC is deeply honored to be a part of the “Quad Cancer Moonshot team,” collaborating with our partners to take bold action against #cervicalcancer in the Asia Pacific region. Together, we are committed to eliminating this disease for a healthier future.
Read More
Rising from WCC 2024: The Call to Eliminate Cervical Cancer and Our First Victory Over Cancer
The discussions at #WCC2024 ignited a powerful sense of hope and urgency. The path to eliminating #HPV and #cervicalcancer is clear, but it demands bold action—now. We are armed with the knowledge, technology, and tools to wipe out this preventable disease, which still claims a woman’s life every two minutes. If we do nothing, that number will rise to a woman every 90 seconds by 2050, unleashing untold devastation on families, communities, and nations alike.
We have no excuse to let this happen. The tools to end these unnecessary deaths are in our hands: #HPVvaccination, #screening, and #earlytreatment. These are not just medical interventions; they are weapons in a fight we can win.
The healthcare community has made strides, but that is not enough—we need a united public movement to finish this fight. The time is now to mobilize. We must arm people with the knowledge to demand the care they deserve: HPV vaccinations, self-screening for cervical cancer, and access to life-saving treatments. The HPV vaccine isn’t just a shield against cervical cancer—it prevents six different cancers across all genders. This is not a women’s issue—it’s a global fight that impacts us all.
We must also turn our focus to low- and middle-income countries, where the toll is highest. Equity in healthcare is non-negotiable. Technology and innovation are our keys to ensuring every woman, no matter where she lives, has the same chance to live free from this disease.
History has shown us the power of grassroots movements. The fight against HIV/AIDS was won through public activism, relentless awareness, and demand for care. Now, we must spark that same fire in the battle against HPV-related cancers—starting with cervical cancer.
Healthcare leaders, advocates, and the public must rise as one. Let this be our rallying cry: We will not wait. We will not lose more lives. We will make cervical cancer the first cancer we defeat.
Together, we can rewrite the future, eliminating cervical cancer and ensuring a healthier world for generations to come. The time for action is now—let’s claim our first victory over cancer.#GlobalCancerMoonshot
GIAHC joins President Biden’s Cancer Moonshot delegation to India (August 2024)
It has been a great honor to be a part of President Biden’s Cancer Moonshot delegation to India and to participate in the US-India Cancer Dialogue Initiative.
It was heartening to see scientists, researchers, clinicians, industry professionals, patient advocates, and governments from both sides come together to share perspectives in areas of:
- AI enabled Innovation for Cancer Care
- Novel Therapeutics – Vaccines, Immunotherapy, and other Biologicals
- Cancer Genomics and Precision Medicine
- Cost Effective Equitable Cancer Therapy and Implementation Science
- Cancer Clinical Trials: Priorities, Regulatory Landscape& Capacity Building
- Holistic Survivorship Care
- Common Molecular links underlying Cancer, CVDs/NCDs –Role of Complementary & Alternative Medicines
Dr. Krishnan made a presentation under “Cost Effective Equitable Cancer Therapy and Implementation Science” highlighting the burden of cervical cancer despite it being an almost completely preventable disease, with HPV vaccination, screening and early treatment that could be administered even in remote parts of the developing world.
We hope the invigorating discussions around challenges and possible solutions will mark the beginning of a renewed commitment by both countries to collaborate and achieve our first “win” over cancer.
GIAHC visits Capitol Hill and the White House with its youngest members
We are delighted to be joined by teen girls from the GIAHC Young leaders’ group who accompanied by their mothers/ aunts visited Capitol Hill and the White House President Biden Cancer Moonshot team to advocate for the elimination of HPV cancers . This event was organized by HPV Cancers Alliance as a part of their Healthy Girls, Healthy Women 2024 initiative. Please see flyer for details.
GIAHC is proud to share a report of its work with partners at PHRII , Mysuru India for International HPV Awareness Day.
GIAHC partners with Public Health Research Institute of India (PHRII) Mysore, to mark International HPV Awareness Day.
On March 4th, in honor of International HPV Awareness Day, GIAHC and partners at PHRII in Mysore, India, will be hosting events to raise awareness about HPV and highlight the significance of vaccination, screening, and early treatment in preventing cervical cancer. These activities will span the week, leading up to a screening camp on March 8th, International
Women’s Day.
GIAHC is pleased to announce a report of its collaborative efforts with AMWA, UICC, and HealthyWomen
GIAHC is thrilled to announce its partnership with CAPED India. The two organizations
will work together to raise awareness around HPV vaccination to parents in India and to
facilitate the development of an educational series for health care providers around
cervical cancer screening and early treatment.
World Cancer Day 2024
GIAHC, in collaboration with the Public Health Research Institute (PHRII) at Mysuru, India, has been actively involved in raising awareness about HPV and cervical cancer elimination. Leading up to World Cancer Day, PHRII, with support from partners like JSS Academy of Higher Education and Research and sponsorship from Sun Pharma’s Corporate Social Responsibility wing, initiated a program to vaccinate 193 adolescent girls in rural Mysuru District against Human Papillomavirus (HPV), the primary cause of cervical cancer. This innovative initiative integrated vaccination with school-based community education, providing interactive sessions to schoolgirls, teachers, and parents on HPV, cervical cancer, and prevention. The girls were administered the Gardasil-9 vaccine, safeguarding them against nine high-risk HPV types. Aligned with the WHO’s Global Strategy for Cervical Cancer Elimination, the program aims for 90% vaccination coverage, 70% screening for women by ages 35 and 45, and 90% treatment for identified cervical disease by 2030. Cervical cancer, ranking as the second most common cancer in Indian women, remains a significant health challenge, underscoring the importance of initiatives like Mysuru’s in raising awareness and promoting vaccination and screening.
Photos: Courtesy of PHRII, Mysuru, India
WHITE HOUSE VISIT- CERVICAL CANCER FORUM
On Thursday, January 25, the Biden Cancer Moonshot hosted the White House Cervical Cancer
Forum to recognize Cervical Cancer Awareness Month and spur action on education,
prevention, early detection, and treatment.
Photos: Drs. Shobha S. Krishnan, Eliza Lo Chin, Douglas Lowy, Danielle Carnival, Anna
Giuliano, Heather White Kathryn Kundrod, Catharine Young, including Tamika and Friends,
Justine Almada, Alayna Effron, Eve McDavid and many more distinguished invitees.
Congressional Briefing, 1/24/2024
Dr. Krishnan was invited to speak at this congressional briefing organized by HealthyWomen.
Us vs. HPV Prevention Week
A one-week series of webinars, social media campaigns, local events and more to promote awareness about HPV and HPV-related diseases, co-hosted with the American Medical Women’s Association.
